United States (US) Computational Biology Market (2025-2031) | Growth, Share, Segmentation, Analysis, Competitive Landscape, Outlook, Value, Forecast, Size & Revenue, Industry, Trends, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Computational Biology Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Computational Biology Market - Industry Life Cycle

3.4 United States (US) Computational Biology Market - Porter's Five Forces

3.5 United States (US) Computational Biology Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) Computational Biology Market Revenues & Volume Share, By End-User, 2021 & 2031F

3.7 United States (US) Computational Biology Market Revenues & Volume Share, By Service, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine leading to the adoption of computational biology solutions.

4.2.2 Technological advancements in data analytics and machine learning driving growth in computational biology applications.

4.2.3 Growing emphasis on precision medicine and genomics research boosting the computational biology market.

4.3 Market Restraints

4.3.1 High costs associated with computational biology software and infrastructure hindering market expansion.

4.3.2 Data security and privacy concerns limiting the adoption of computational biology solutions.

4.3.3 Lack of skilled professionals in computational biology impeding market growth.

6.1 United States (US) Computational Biology Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) Computational Biology Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) Computational Biology Market Revenues & Volume, By Cellular, 2021- 2031F

6.1.4 United States (US) Computational Biology Market Revenues & Volume, By Biological Simulation, 2021- 2031F

6.1.5 United States (US) Computational Biology Market Revenues & Volume, By Drug Discovery, 2021- 2031F

6.1.6 United States (US) Computational Biology Market Revenues & Volume, By Disease Modeling, Others, 2021- 2031F

6.2 United States (US) Computational Biology Market, By End-User

6.2.1 Overview and Analysis

6.2.2 United States (US) Computational Biology Market Revenues & Volume, By Academics, 2021- 2031F

6.2.3 United States (US) Computational Biology Market Revenues & Volume, By Commercial, 2021- 2031F

6.2.4 United States (US) Computational Biology Market Revenues & Volume, By Pharmaceutical, 2021- 2031F

6.3 United States (US) Computational Biology Market, By Service

6.3.1 Overview and Analysis

6.3.2 United States (US) Computational Biology Market Revenues & Volume, By In-House, 2021- 2031F

6.3.3 United States (US) Computational Biology Market Revenues & Volume, By Contract, 2021- 2031F

7.1 United States (US) Computational Biology Market Export to Major Countries

7.2 United States (US) Computational Biology Market Imports from Major Countries

8.1 Number of research publications citing the use of computational biology tools and techniques in the US.

8.2 Adoption rate of computational biology solutions in pharmaceutical and biotechnology companies in the US.

8.3 Number of partnerships and collaborations between academic institutions, research organizations, and computational biology companies in the US.

9.1 United States (US) Computational Biology Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) Computational Biology Market Opportunity Assessment, By End-User, 2021 & 2031F

9.3 United States (US) Computational Biology Market Opportunity Assessment, By Service, 2021 & 2031F

10.1 United States (US) Computational Biology Market Revenue Share, By Companies, 2024

10.2 United States (US) Computational Biology Market Competitive Benchmarking, By Operating and Technical Parameters